Skip to the main content.

1 min read

Publication | Single-use disposable technologies for biopharmaceutical manufacturing

Gottschalk, U., Shukla, A. Single-use disposable technologies for biopharmaceutical manufacturing, Trends in Biotechnology, 31(3), 147-154, 2013.


Abstract
The manufacture of protein biopharmaceuticals is conducted under current good manufacturing practice (cGMP) and involves multiple unit operations for upstream production and downstream purification. Production facilities, until recently, relied on the use of relatively inflexible, hard-piped equipment including large stainless steel bioreactors and tanks to hold product intermediates and buffers. Now, however, there is an increasing trend towards the adoption of single-use technologies across the manufacturing process. Technical advances have now made an end-to-end single-use manufacturing facility possible, but several aspects of single-use technology require further improvement and are continually evolving. This article provides a perspective on the current state-of-the-art in single-use technologies and highlights trends that will increase the market penetration of disposable manufacturing and improve performance in the future.

The article includes the following highlights:

  • Single-use disposable technologies in the manufacturing of biopharmaceuticals
  • Advantages and limitations of single-use manufacturing
  • Single-use systems for protein drug substance production process: key features, current scales and vendors
  • Disposables reduce cost of clinical manufacturing and co-locating manufacturing

Keywords
Single-use manufacturing; Disposables; cGMP

Get the Full Article Here

 

1 min read

Publication | Vertical Integration of Disposables in Biopharmaceutical Drug Substance Manufacturing

Shukla, A., Mostafa, S., Wilson, M., Lange, D. Vertical Integration of Disposables in Biopharmaceutical Drug Substance Manufacturing, Bioprocess...

Read More
Faster Determination of Dynamic Binding Capacity – Q&A With KBI’s Scientific Team

3 min read

Faster Determination of Dynamic Binding Capacity – Q&A With KBI’s Scientific Team

Biopharmaceuticals are a significant growth area for the pharmaceutical industry, as these therapeutics can address unmet medical needs through novel...

Read More
Choosing The Ideal CDMO Partner For Cell Line Development

3 min read

Choosing The Ideal CDMO Partner For Cell Line Development

Author: Séverine Fagète, Ph.D. The commercial production of recombinant proteins, including antibodies and enzymes, hinges on the generation and...

Read More